Found: 39
Select item for more details and to access through your institution.
Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 7, p. 1, doi. 10.1007/s11912-019-0808-0
- By:
- Publication type:
- Article
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27312-6
- By:
- Publication type:
- Article
Lenalidomide maintenance following high‐dose therapy and autologous haematopoietic stem cell transplantation in chemo‐resistant or high‐risk non‐Hodgkin lymphoma: A phase I/II study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 1, p. 116, doi. 10.1111/bjh.18821
- By:
- Publication type:
- Article
Sequential loss of B‐cell target antigens in multiply relapsed high‐grade B‐cell lymphoma treated with targeted therapies.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. e71, doi. 10.1111/bjh.18333
- By:
- Publication type:
- Article
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 275, doi. 10.1111/bjh.14228
- By:
- Publication type:
- Article
Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 3, p. 404, doi. 10.1111/bjh.13975
- By:
- Publication type:
- Article
Organ sparing of linac‐based targeted marrow irradiation over total body irradiation.
- Published in:
- Journal of Applied Clinical Medical Physics, 2019, v. 20, n. 11, p. 69, doi. 10.1002/acm2.12742
- By:
- Publication type:
- Article
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 297, doi. 10.1007/s10637-018-0655-0
- By:
- Publication type:
- Article
BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1180, doi. 10.1002/ajh.27291
- By:
- Publication type:
- Article
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2142046, doi. 10.1001/jamanetworkopen.2021.42046
- By:
- Publication type:
- Article
T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2824, doi. 10.3390/cancers15102824
- By:
- Publication type:
- Article
Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.
- Published in:
- Cytometry. Part A, 2014, v. 85, n. 9, p. 798, doi. 10.1002/cyto.a.22485
- By:
- Publication type:
- Article
Bortezomib for the treatment of mantle cell lymphoma: an update.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 4, p. 196, doi. 10.1177/2040620716648566
- By:
- Publication type:
- Article
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.745320
- By:
- Publication type:
- Article
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01941
- By:
- Publication type:
- Article
Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e738, doi. 10.1016/j.clml.2022.04.006
- By:
- Publication type:
- Article
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 x 10<sup>9</sup>/L): Final Analysis of an Open-Label Phase 2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 336, doi. 10.1016/j.clml.2021.10.016
- By:
- Publication type:
- Article
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
- By:
- Publication type:
- Article
Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 799, doi. 10.1016/j.clml.2021.06.015
- By:
- Publication type:
- Article
ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S377, doi. 10.1016/S2152-2650(21)01861-9
- By:
- Publication type:
- Article
Poster: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01495-6
- By:
- Publication type:
- Article
Oral Abstract: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01278-7
- By:
- Publication type:
- Article
Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exposure–response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 1, doi. 10.1007/s00280-022-04487-3
- By:
- Publication type:
- Article
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 13, doi. 10.1007/s00280-022-04486-4
- By:
- Publication type:
- Article
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 884, doi. 10.1002/hon.3192
- By:
- Publication type:
- Article
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 626, doi. 10.1002/hon.3034
- By:
- Publication type:
- Article
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma ‐ specific venous thrombosis prediction models.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. 918, doi. 10.1002/ajh.25837
- By:
- Publication type:
- Article
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 778, doi. 10.1002/ajh.24082
- By:
- Publication type:
- Article
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 14, p. 1880, doi. 10.3390/cells12141880
- By:
- Publication type:
- Article
Factors Influencing Patients' Intention to Perform Physical Activity During Hematopoietic Cell Transplantation.
- Published in:
- Oncology Nursing Forum, 2019, v. 46, n. 6, p. 746, doi. 10.1188/19.ONF.746-756
- By:
- Publication type:
- Article
Analysis of epigenetic aging in vivo and in vitro : Factors controlling the speed and direction.
- Published in:
- Experimental Biology & Medicine, 2020, v. 245, n. 17, p. 1543, doi. 10.1177/1535370220947015
- By:
- Publication type:
- Article
Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance.
- Published in:
- Clinical Transplantation, 2015, v. 29, n. 9, p. 851, doi. 10.1111/ctr.12595
- By:
- Publication type:
- Article
Non-Hodgkin's Lymphoma in the Elderly.
- Published in:
- Drugs & Aging, 2010, v. 27, n. 3, p. 211, doi. 10.2165/11531550-000000000-00000
- By:
- Publication type:
- Article
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01316-1
- By:
- Publication type:
- Article
In relapsed or refractory diffuse large B‐cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 76, doi. 10.1002/jha2.816
- By:
- Publication type:
- Article
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00327
- By:
- Publication type:
- Article